申请人:Boehringer Ingelheim International GmbH
公开号:US20210403482A1
公开(公告)日:2021-12-30
The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
本公开提供了一些噻唑酮衍生物,它们是暂时性受体电位蛋白1(TRPA1)的抑制剂,因此可用于治疗通过抑制TRPA1可治疗的疾病。还提供了含有这些衍生物的药物组合物,以及制备这些化合物的方法。